Auxilium Pharmaceuticals Inc $18.47

down -0.08


22/8/2014 04:00 PM  |  NASDAQ : AUXL  
Industries : Drugs / Drug Related Products
Get Trend Analysis Icon Get AUXL Trend Analysis - it has underperformed the S&P 500 by 16%

Partner Headlines

  1. Markets Mixed; Dollar Tree Profit Misses Estimates

    Benzinga
  2. Morning Market Movers

    Benzinga
  3. Benzinga's Top #PreMarket Gainers

    Benzinga
  4. US Stock Futures Rise; Jobless Claims Report In Focus

    Benzinga
  5. UPDATE: Auxilium Pharma Reports Wider-Than-Expected Q2 Loss

    Benzinga
  6. Earnings Scheduled For August 7, 2014

    Benzinga
  7. Salix Pharma Stock Falls Despite Tax-Inversion Deal

    IBD
  8. R.F. Lafferty Devalues Auxilium, QLT Deal

    Benzinga
  9. Benzinga's M&A Chatter for Thursday June 26, 2014

    Benzinga
  10. Auxilium swaps stock for QLT

    IBD
  11. Auxilium Acquiring QLT For New Products, Low Taxes

    IBD
  12. Aegis Capital Initiates Coverage On Auxilium Pharmaceuticals, Favors Acquisition

    Benzinga
  13. Morning Market Movers

    Benzinga
  14. Benzinga's Top #PreMarket Gainers

    Benzinga
  15. US Stock Futures Flat Ahead Of Jobless Claims, Consumer Spending Data

    Benzinga
  16. UPDATE: Auxilium Pharmaceuticals To Merge With Canadian Biotechnology Company ...

    Benzinga
  17. Market Wrap For June 11: Momentum Hit, Dow Suffers Triple Digit Loss

    Benzinga
  18. Mid-Afternoon Market Update: ULTA Salon Remains Steady After Strong Results; ...

    Benzinga
  19. Mid-Day Market Update: ULTA Salon Rises After Strong Results; Orexigen ...

    Benzinga
  20. Mid-Morning Market Update: Markets Drop; H&R Block Posts Higher Profit

    Benzinga
  21. Morning Market Losers

    Benzinga
  22. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  23. Auxilium Testim sales fall 76%

    IBD
  24. Earnings Scheduled For May 5, 2014

    Benzinga
  25. Mid-Day Market Update: Twitter Drops On Earnings; Pepco Shares Gain

    Benzinga
  26. Morning Market Losers

    Benzinga
  27. Benzinga's Top #PreMarket Losers

    Benzinga
  28. Auxilium Pharma to Present XIAFLEX Data at Urology Meeting

    Benzinga
  29. Biotech Auxilium Boosts Position In Men's Health Care

    IBD
  30. Benzinga's Top Downgrades

    Benzinga
  31. UPDATE: Morgan Stanley Downgrades Auxilium Pharmaceuticals as Growth May ...

    Benzinga
  32. US Stock Futures Edge Higher Ahead Of Jobless Claims, Factory Orders Data

    Benzinga
  33. Auxilium guidance cautious

    IBD
  34. Auxilium Q4 Beats Estimates, But Guidance Cautious

    IBD
  35. Benzinga's M&A Chatter for Wednesday January 29, 2014

    Benzinga
  36. Auxilium Pharmaceuticals Presents Interim Data on XIAFLEX for Retreatment ...

    Benzinga
  37. New ED Drug: Analysis of Vivus’s Prospects

    YCharts
  38. Auxilium Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome ...

    Benzinga
  39. Auxilium gets nod from FDA

    IBD
  40. Mid-Afternoon Market Update: Markets Gain on Jobs Number; InterOil Falls ...

    Benzinga
  41. Auxilium Xiaflex Drug Wins New Label, Stock Jumps

    IBD
  42. Auxilium Presented New Analyses of XIAFLEX Peyronie's Disease Data at SMSNA ...

    Benzinga
  43. Auxilium Announces Results Of The XIAFLEX In Dupuytren's MULTICORD Contracture ...

    Benzinga
  44. UPDATE: Auxilium Posts Upbeat Q3 Profit

    Benzinga
  45. Vivus, Auxilium up on deal

    IBD
  46. Vivus, Auxilium Gain On Impotence Drug Deal

    IBD
  47. Auxilium Pharmaceuticals Announces License Agreement with Vivus for Marketing ...

    Benzinga
  48. Auxilium Raises Additional $50M

    Benzinga
  49. RBC Sees 10-15% Upside In Auxilium Shares On FDA Okay Of Xiaflex, 20% Downside ...

    Benzinga
  50. Auxilium Pharmaceuticals Announces Issuance of $350.0M of 1.50% Convertible ...

    Benzinga
Trading Center